OIP — The Opportunity Intelligence PlatformMy OIPOIP / Government Intelligence
Preparing the stored Government Intelligence discovery view.
OIP / Government Intelligence / Opportunity detail
Source: Stored live-derived Government dataNational Institutes of Health
OIP derived this review page from stored live-derived Government Intelligence source records. The official source and issuing agency remain authoritative.
Opportunity Intelligence Platform is an independent service and is not affiliated with or endorsed by the U.S. Government. Official notices, amendments, attachments, eligibility requirements, funding terms, and deadlines remain under source control.
OIP scores and explanations are informational and do not guarantee eligibility, suitability, compliance, contract award, or financial outcome.
Public and State controlled institutions of higher education; Private institutions of higher education
4 warning(s) require review.
Objective score, derived by OIP · How it works
Publication decision: Publish with warning
Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) -- a Grant (Grant) issued by National Institutes of Health.
Objective Government score 72 for grants-gov-358829, computed from source evidence and Government scoring configuration.
difficulty (insufficient_evidence): difficulty could not be scored: no application-complexity, preparation-burden, or applicant-cost evidence is available for this opportunity beyond generic boilerplate. time_required (insufficient_evidence): time_required could not be scored: no application-complexity, preparation-burden, or applicant-cost evidence is available for this opportunity beyond generic boilerplate. capital_required (insufficient_evidence): capital_required could not be scored: no application-complexity, preparation-burden, or applicant-cost evidence is available for this opportunity beyond generic boilerplate. novelty (insufficient_evidence): novelty could not be scored: no current Government source provides a reliable per-record signal for whether an opportunity is genuinely novel versus long-standing.
12 evidence record(s) support this pipeline result.
Next action: Review the official Grants.gov opportunity and follow the listed application package instructions.
95/100 · Ok
evidence_quality reflects a federal-source baseline plus completeness of deadline, funding value, eligibility, and official-source fields on this specific record.
90/100 · Ok
confidence reflects OIP's confidence in its own interpretation of this record's lifecycle and funding-value status, not confidence that any applicant will qualify.
78/100 · Ok
potential_value reflects the disclosed award ceiling or floor for this specific opportunity.
48/100 · Ok
urgency reflects the number of days remaining until the disclosed application deadline.
No numeric value · Insufficient Evidence
difficulty could not be scored: no application-complexity, preparation-burden, or applicant-cost evidence is available for this opportunity beyond generic boilerplate.
No numeric value · Insufficient Evidence
time_required could not be scored: no application-complexity, preparation-burden, or applicant-cost evidence is available for this opportunity beyond generic boilerplate.
No numeric value · Insufficient Evidence
capital_required could not be scored: no application-complexity, preparation-burden, or applicant-cost evidence is available for this opportunity beyond generic boilerplate.
Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
$.detail.opportunityTitle · Field Mapping · 98/100 confidence
358829 / PAR-25-414
$.detail.id · Field Mapping · 99/100 confidence
National Institutes of Health
$.detail.synopsis.agencyName · Field Mapping · 97/100 confidence
Grant
$.detail.synopsis.fundingInstruments · Field Mapping · 96/100 confidence
The SuRE program supports research capacity building at eligible higher education institutions by funding investigator-initiated biomedical research inbasic, social, clinical, behavioral, or translational science that falls in the mission areas of the NIH. The purpose of SuRE awards is to provide support for investigator-initiated research at resource-limited institutions by full-time faculty who are not currently funded by any NIH Research Project Grants (RPGs) with the exception of SuRE or SuRE-First awards, to furnish students with high-quality undergraduate and/or graduate research experiences, and to enhance the institutional scientific research culture.
$.detail.synopsis.synopsisDesc · Field Mapping · 94/100 confidence
2025-06-13T04:00:00.000Z
$.detail.synopsis.postingDate · Field Mapping · 96/100 confidence
2028-09-07T00:00:00.000Z
$.searchHit.closeDate · Field Mapping · 92/100 confidence
Applicant types: Public and State controlled institutions of higher education; Private institutions of higher education
$.detail.synopsis.applicantTypes · Field Mapping · 94/100 confidence
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
$.detail.synopsis.applicantEligibilityDesc · Field Mapping · 94/100 confidence
Official source materials control eligibility, deadlines, amendments, attachments, and funding terms.
Open official source50/100 · Ok
risk reflects the number of material evidence gaps on this record (undisclosed value, missing deadline, unlisted eligibility, or a stale source date), not ordinary competitive uncertainty.
No numeric value · Insufficient Evidence
novelty could not be scored: no current Government source provides a reliable per-record signal for whether an opportunity is genuinely novel versus long-standing.
100000.00
$.detail.synopsis.awardCeiling · Field Mapping · 92/100 confidence
2025-06-13T16:28:05.000Z
$.detail.synopsis.lastUpdatedDate · Field Mapping · 88/100 confidence
PAR-25-414-Full-Announcement.html
$.detail.synopsisAttachmentFolders[0].synopsisAttachments[0] · Field Mapping · 90/100 confidence